Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study
GlaxoSmithKline
GlaxoSmithKline
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Xiamen Innovax Biotech Co., Ltd
Sunnybrook Health Sciences Centre
Medstar Health Research Institute
GlaxoSmithKline
GlaxoSmithKline
CHU de Reims
Merck Sharp & Dohme LLC
Medical University of Lublin
Shandong Cancer Hospital and Institute
University of Kansas Medical Center
Boston Medical Center
Fox Chase Cancer Center
Duke University
National Cancer Institute (NCI)
London School of Hygiene and Tropical Medicine